Healthcare Professional (HCP) Survey to Assess the Effectiveness of the Additional Risk Minimization Measures (aRMM) for Casgevy® (exagamglogene autotemcel)

First published 08/08/2025

Last updated 08/08/2025

EU PAS number:

EUPAS1000000704

Study

Planned

Documents

Study protocol

Initial protocol

Vertex HCP Survey (290-102) Protocol Version 3.0_ 01April2025_Redacted.pdf

English (4.2 MB - PDF) View document

Study results

Study report

Other information

Secondary tabs